extension to mta announced, page-23

Definitely a positive announcements, it's all in the title. In particular, pay attention to the first 2 words...

3M REQUESTS 60 DAY EXTENSION TO MTA

OBJ Limited (ASX: OBJ) announced on 4 November 2009 that initial in vitro testing by 3M was expected to be completed by 1 February 2010.

The testing undertaken by 3M required an extension of time to the initial agreement.

OBJ now advises that it has granted the extension to the Materials Transfer Agreement (MTA) to 3M Corporation to allow for the completion of additional testing.

3M is an American multinational corporation with 79,000 employees operating in 60 countries generating global sales in excess of US$25 billion in 2008.

The Materials Transfer Agreement sets the parameters for an initial in vitro testing program to evaluate the performance of the eM‐patch technology in conjunction
with 3M drug delivery platforms and proprietary formulations.

The Company will update shareholders on progress of the program.
‐ Ends ‐